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Introduction
In normal subjects arterial baroreflexes play
a key role in short-term blood pressure adjustments
to a variety of environmental stresses, thereby
maintaining circulatory homeostasis. These re-
sponses are mediated by the sympathetic and par-
asympathetic nervous systems through their effects
on heart rate, venous return, contractility and pe-
ripheral resistance. The evaluation of baroreflex
sensitivity (BRS) has recently found unexpected
exploitations as alterations in the baroreflex
control of heart rate have been associated with an
increased propensity for cardiac mortality and
sudden cardiac death [1].
Among several quantitative approaches deve-
loped for evaluating BRS including the analysis of
reflex responses to pharmacological or mechanical
manipulations of baroreceptors, this article de-
scribes the use of vasoactive drugs and the analy-
sis of spontaneously occurring changes in blood
pressure and heart rate.
Vasoactive drugs
An increase in systemic arterial pressure in-
creases the firing rate of baroreceptors which caus-
es vagal excitation and sympathetic inhibition, thus
decreasing heart rate; BRS can be quantified as the
measure of the reflex bradycardia which follows the
blood pressure rise induced by injection of an alpha-
-adrenoreceptor stimulant [2]. Generally, an increase
in systolic arterial pressure by 20–40 mm Hg
activates baroreceptors to operate in the linear por-
tion of their reflex response.
In normal subjects 25–100 mcg of phenyle-
phrine are flushed into a vein to increase systolic
arterial pressure (SAP) by 20–40 mm Hg. The ad-
ministration of the drug is performed in standard-
ized laboratory conditions including a quiet, tem-
perature controlled environment, during a contin-
uous and simultaneous recording of one lead
electrocardiographic signal and beat-to-beat arterial
pressure. Heart rate and blood pressure are record-
ed continuously because, given the rapidity of va-
gal responses, it is commonly assumed that at nor-
mal resting heart rates each heart period value is
mainly related on a cause-effect basis to the previ-
ous systolic pressure peak, and that this relation is
linear. Prolongations of successive RR intervals
with respect to baseline values (i.e. pre-injection)
are therefore plotted as a function of preceding SAP
changes and an analysis window is selected between
the beginning and the end of the first significant
(> 20 mm Hg) increase in SAP. The slope of the
regression line fitted to the selected points (ex-
pressed as ms/mm Hg) — that is, the absolute in-
crease in RR interval produced by a 1 mm Hg rise
in SAP — represents BRS. Pearson’s correlation
coefficient is used to test the goodness of the linear
association between SAP and RR interval changes.
Several injections are generally repeated at
intervals of a few minutes and the corresponding
slopes are averaged in order to reduce measure-
ment variability between tests. The final slope is
generally obtained by at least three slopes with the
higher correlation coefficients. Estimates of BRS
are very similar when SAP is measured directly
from the radial or brachial artery or from a nonin-
vasive pressure monitor [3, 4].
In normal young subjects average BRS values of
14.8 ± 9.2 ms/mm Hg (SD) [5], 16.0 ± 1.8 ms/mm Hg
(SEM) [6] and 16.4 ± 4.2 ms/mm Hg [7] have been
reported. When analyzing a test of BRS such a slope
is generally interpreted as the result of the inter-
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play between effective vagal reflexes and tonic sym-
pathetic activity (Fig. 1). By contrast, a flat slope
may be due to abnormal vagal response or is the
result of the inability of vagal reflexes to counter-
balance sympathetic activation (Fig. 2). The major
criticisms the phenylephrine test has been subject-
ed to is that the phenylephrine injection, by acute-
ly increasing left ventricular afterload, may activate
other receptors such as cardiac mechanoreceptors
and that  the observed response is the results of
multiple factors (including the stiffness of the arterial
wall and transduction processes, the central inte-
gration, the sensitivity of the sinus node etc.). How-
ever, when BRS is used to draw inferences on the
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Figure 1. Example of a sensitive BRS. On the left beat-to-beat changes in systolic blood pressure (SAP) (dotted line)
and in RR interval (continuous line) with respect to baseline values are reported. Analysis is limited to the first major
increase in systolic arterial pressure with the attendant changes in RR interval (points included between dotted lines).
These points are used for calculation of the regression line (on the right). The increase in SAP is greater than
20 mm Hg and is accompanied by a consistent increase in RR interval. Accordingly the slope of the regression line is
20 ms/mm Hg and represents a response primarily characterized by an increase in efferent vagus nerve activity to
the sinus node.
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Figure 2. Example of a poor BRS. Detailed description as in Figure 1. The increase in SAP is accompanied by
a modest increase in RR interval and the slope of the regression line is 1.4 ms/mm Hg and represents a response
characterized by weak vagal reflexes.
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amount of autonomic mediators (acetylcholine,
norepinephrine) released at cardiac level, a most
important question for cardiac electrophysiology,
this is no longer a limitation. Indeed, the fact that
vasoactive drugs induce a simultaneous activation
of multiple reflexogenic areas is actually an advan-
tage for the purpose of using BRS as a measure of
net autonomic balance to the heart.
Several methodological aspects of the phenyle-
phrine technique deserve some comments and con-
siderations when dealing with the application of this
test in patients.
Rate of infusion
In patients after a recent myocardial infarction [8],
for “safety reasons”,  phenylephrine has been injected
over 30 s. However, provided that patients with un-
stable angina and uncontrolled arterial hypertension
(> 160/90 mm Hg) are not tested, no ischemic episodes
have been reported as a consequence of phenylephrine
administration. At variance, in patients with heart fail-
ure in stable clinical condition it may be necessary to
increase the rate of infusion of the drug as these pa-
tients show slower blood pressure changes [9].
Dosage of phenylephrine
In post myocardial infarction patients a dose of
2 mcg/kg is generally sufficient to obtain the re-
quired blood pressure change. If blood pressure
does not increase as required additional injections
will be made, increasing the dosage of phenyle-
phrine by increments of 25 mcg. In patients with
congestive heart failure [9] even higher doses (up
to 10 mcg/kg) have been used to elicit barorecep-
tor responses.
Correlation coefficient
The value of the correlation coefficient also
deserves several comments. When the correlation
coefficient is higher than 0.7–0.8, and the pairs of
data included in the analysis are greater than 10,
a test of significance is not required since this cor-
relation is obviously statistically significant. For
lower values a test of significance is required to test
the association between systolic arterial pressure
and RR interval changes. When BRS values are near
zero (–0.5 ÷ +0.5 ms/mm Hg) as it is commonly
observed among patients with severely depressed
left ventricular function and congestive heart failure,
the correlation coefficient is obviously not significant.
However, provided an adequate (> 15 mm Hg)
systolic arterial pressure increase has been ob-
tained, the BRS value is retained, independently of
the not significant correlation coefficient (Fig. 3) [9].
In fact, this slope faithfully describes the observed
phenomenon, namely the virtual absence of
response between pressure elevation and RR inter-
val. Paradoxically in some cases, (as in the trans-
plant patient of Fig. 4), a BRS value near to 0 may
have a statistically significant correlation coeffi-
cient. Finally, the correlation coefficient is not
simply related to the scatter of data in the regres-
sion analysis as in some cases it can be improved
by changing the lag between systolic pressure
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Figure 3. Example of a poor BRS in a patient with severe congestive heart failure. Detailed description as in Figure 1.
The increase in SAP (> 30 mm Hg) is accompanied by small, erratic changes in RR interval. The slope of the
regression line is near to 0 and the correlation coefficient is not statistically significant.
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pulses and RR intervals. Abnormal respiratory pat-
terns such as periodic breathing or Cheyne-Stokes
respiration which are often observed in patients
with heart failure [10] frequently induce such an
erratic behavior of heart rate that definitely affects
the correlation coefficient. In such cases this erratic
behavior of heart rate can be markedly attenuated
and a measurable BRS is obtained by the use of
controlled breathing.
Overall, BRS decreases whenever the auto-
nomic balance shifts toward sympathetic dominance
and increases whenever the autonomic balance
shifts toward parasympathetic dominance. Cardio-
vascular disease may alter baroreceptor function,
primarily because of a decreased capability to acti-
vate vagal reflexes [6]. A case in point is represent-
ed by myocardial infarction that often significantly
impairs baroreflex sensitivity. The underlying
mechanism has not yet been demonstrated; however,
a tenable hypothesis has been advanced [11, 12]. It was
specifically proposed that myocardial infarction could
often augment sympathetic afferent traffic and that
this, in turn, would reduce vagal efferent activity. The
presence of a necrotic and noncontracting segment
may indeed alter the geometry of the beating heart
and increase beyond normal the firing of sympathetic
and vagal afferent fibers by mechanical distortion of
their sensory endings [13]. Excitation of cardiac sym-
pathetic afferent fibers inhibits tonic vagal efferent
activity and blunts the baroreceptor-mediated reflex
increase in vagal activity elicited by a blood pressure
rise. The mean BRS was 7.2 ± 4.6 ms/mm Hg (SD)
and 3.9 ± 4.0 ms/mm Hg (SD) in two large series of
patients with a previous myocardial infarction [14] and
with congestive heart failure [9] respectively.
While vasoconstrictor drugs mainly explore the
vagal component of the baroreceptor control of
heart rate, vasodilators have been used to obtain
information on the sympathetic branch of heart rate
control [15]. Baroreflex slopes obtained by vasodi-
lators are lower than those obtained by increasing
arterial pressure to a similar extent, suggesting that
the two responses are not symmetric [16].
Analysis of spontaneous
baroreflex sensitivity
Based on the evidence that the baroreflexes do
not act only to control abrupt changes in arterial pres-
sure, but are continuously activated by small variations
of systolic arterial pressure, more recent — computer
based-techniques, have allowed to evaluate baroreflex
cardiovascular control without externally induced
changes in arterial pressure, by the analysis of sponta-
neously occurring fluctuations in arterial pressure and
heart rate. Two basic approaches have been proposed
and validated: one based on “time domain” and one
based on “frequency domain” measurements.
At variance with the previously described
measures of BRS which have been standardized in
supine position, use of these new approaches has
offered a detailed assessment of the interaction
between baroreflex function and the daily life
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Figure 4. Example of a poor BRS in a patient with recent heart transplantation. Detailed description as in Figure 1.
The increase in SAP is accompanied by a negligible change in RR interval. The slope of the regression line is near to 0,
however the correlation coefficient is statistically significant (p < 0.05).
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modulation of cardiovascular parameters [17]. How-
ever for clinical purposes, one ECG lead and beat-
to-beat blood pressure recordings are continuous-
ly obtained for a given period of time in supine rest-
ing position during spontaneous breathing and/or
during paced breathing.
Sequence methods of
baroreflex sensitivity evaluation
The sequence method, described by Parati
et al. [18], is based on the identification of three or
more consecutive beats in which progressive in-
creases in systolic blood pressure are followed by
progressive lengthening in RR interval or, progres-
sive decreases in systolic blood pressure are fol-
lowed by a progressive shortening in RR interval.
The threshold value for including beat-to-beat
systolic blood pressure and RR interval changes in
a sequence are set at 1 mm Hg and 6 milliseconds,
respectively. Similarly to that which is done when
vasoactive drugs are injected, information on the
sensitivity of baroreflex control of heart rate can be
obtained by computing the slope of the regression
line between changes in systolic arterial pressure
and the following changes in RR interval.
The advantages of this method are: strict au-
tomatically used criteria, which significantly restrict
the subjective evaluation of BRS, and allows to sep-
arate calculation of BRS for short-term increasing
and decreasing SAP sequences.
The baroreflex nature of these spontaneous RR
interval/SAP sequences was demonstrated by
showing that in cats the number of sequences mark-
edly dropped (–89%) after the surgical opening of
the baroreflex loop obtained by a sino-aortic den-
ervation.
Spectral methods of
baroreflex sensitivity evaluation
BRS evaluation using the spectral method is
based on the concept that each spontaneous oscil-
lation in blood pressure elicits an oscillation of sim-
ilar frequency in the RR interval by the effect of
arterial baroreflex activity. Two major oscillations
are usually considered: that centered around 0.1 Hz,
within the low frequency (LF) band (0.04 ÷ 0.15 Hz),
and that associated with respiratory activity in the
high frequency (HF) band (0.15 ÷ 0.40 Hz).
Various analysis methods have been described.
According to the technique described by Pagani et
al. [19], the autoregressive approach is used to per-
form univariate and bivariate spectral analysis. The
baroreflex gain is quantified by performing the fol-
lowing steps: 1) estimation of the spectrum of heart
period and SAP and computation of spectral com-
ponents in the LF and HF bands; 2) estimation of
the coherence function; and 3) computation of the
square root of the ratio between the heart period
and the SAP spectral components in both bands
provided that the coherence between these com-
ponents was ≥ 0.5. These two indexes are usually
called alpha-LF and alpha-HF, respectively. In the
method described by Robbe et al. [20], BRS is com-
puted as the mean value of the transfer function in
the frequency region around 0.07 to 0.14 Hz where
the coherence is ≥ 0.5. In one of the modifications
of this method, described by Pinna et al. [21], BRS
is evaluated by averaging the estimated gain func-
tion between 0.04 and 0.15 Hz (LF band) using all
curves regardless of the coherence. Representative
examples are reported in Figure 5. The minimum
recording time necessary for BRS evaluation in this
method amounts about 4 minutes.
Several investigators have proposed that spec-
tral estimations of baroreflex gain are reliable al-
ternatives to the phenylephrine test [19, 20, 22, 23].
However these results have been obtained only in
small groups of normal subjects or hypertensive
patients and have been based on simple correlation
analysis. Moreover, when comparing different
methods for assessing BRS, it is important to em-
phasize that the “true” value of cardiac BRS is un-
known: all the existing methods offer an indirect
estimation of its “true” value. Simply due to the
large amount of clinical data gathered with the phe-
nylephrine test, this technique is still regarded as
the “gold standard” in the assessment of BRS.
We have compared spectral measurements and
the phenylephrine measured BRS in patients with
a previous myocardial infarction and different de-
grees of left ventricular dysfunction [24] and ana-
lyzed the “agreement” between the two approach-
es using a method more appropriate than the cor-
relation coefficient testing for simple linear
dependence [25]. We found that despite a substan-
tial linear association, the agreement between spec-
tral measurements and phenylephrine in the esti-
mation of baroreflex gain is weak because the dif-
ference can be as large as the BRS value being
estimated. It is not surprising that the phenyle-
phrine and spectral methods do not provide similar
quantification of baroreflex gain in cardiac patients.
Besides theoretical and methodological differenc-
es, from a clinical point of view,  the phenylephrine
baroreflex gain — which is the result of the com-
plex interplay of multiple receptor areas and the
hemodynamic burden produced by the after-load
increase — yields information on the „whole”
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Figure 5. Example of the computation of the spectral indexes of Robbe et al. and Pagani et al. Panel A and B show
representative examples of systolic arterial pressure (SAP) and heart period (HP) time series. The corresponding
autoregressive spectra are shown in panels C and D, respectively; the coherence function between SAP and HP in
panel E and the transfer function in panel F. The portion of the transfer function in the frequency region 0.07 to 0.14 Hz,
where the coherence is ≥ 0.5, is plotted in bold. The mean value of this line is the baroreflex gain computed
according to the Robbe technique. The darkened areas PLFSAP, PHFSAP, PLFHP and PHFHP in the two spectra represent the
spectral components involved in the computation of the alpha-LF and alpha-HF, and the dashed-dotted lines in
panels C, D and E indicate the LF and HF central frequencies. The alpha-LF is computed by dividing PLFHP (correspon-
ding to the LF component of SAP) by the PLFSAP and taking the square root. The same holds for alpha-HF, considering
the areas PHFHP and PHFSAP.
636
Folia Cardiol. 2006, Vol. 13, No. 7
www.foliacardiologica.eu
capability of the system to evoke an increase in
vagal activity, whereas the spectral baroreflex gain
yields information on the level of autonomic modu-
lation on a continuous basis. Despite these differ-
ences, in a large series of 317 stable heart failure
patients, we have found that non invasive BRS con-
veys relevant clinical and prognostic information [26].
In summary several methods have been devel-
oped to measure the baroreflex control of heart rate
and blood pressure. Despite theoretical and practi-
cal differences both the invasive and non invasive
estimates of baroreflex sensitivity have been dem-
onstrated to carry prognostic information. Howev-
er differences in clinical relevance should be ad-
dressed in wide populations.
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